American ginseng (Panax quinquefolius L.) attenuates postprandial glycemia in a time-dependent but not dose-dependent manner in healthy individuals

American Journal of Clinical Nutrition

Volumn 73, Issue 4, 2001, Pages 753-758

  Vuksan, V ^a   Sievenpiper, J L ^a   Wong, J ^a   Xu, Z ^a   Beljan Zdravkovic, U ^a   Arnason, J T ^a   Assinewe, V ^a   Stavro, M P ^a   Jenkins, A L ^a   Leiter, L A ^a   Francis, T ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

American ginseng; Dose; Oral glucose tolerance test; Placebo; Postprandial glycemia; Time

Indexed keywords

GINSENG EXTRACT;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; ORAL GLUCOSE TOLERANCE TEST; POSTPRANDIAL STATE;

PANAX GINSENG; PANAX QUINQUEFOLIUS;

EID: 0035081321     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn/73.4.753     Document Type: Article

References (45)

1. Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in US adults: The third National Health and Nutrition Examination Survey, 1988-1994
2. Mortality in adults with and without diabetes in a national cohort of the US population, 1971-1993
3. Trends in alternative medicine use in the United States, 1990-1997: Results of a followup national survey
4. The arrogance of science and the pitfalls of hope
5. Alternative medicine meets science
6. Complementary medicine is booming worldwide
7. Alternative medicine - The risks of untested and unregulated remedies
8. Quantitative methods in research on complementary and alternative medicine. A methodological manifesto
9. Isolation and hypoglycemic activity of quinquefolans A, B, and C, glycans of Panax quinquefolium roots
10. The physiological effects of Aralia, Panax and Eleutherococcus on exercised rats
11. Effect of ginseng radix on GLUT2 protein content in mouse liver in normal and epinephrine-induced hyperglycemic mice
12. Hypoglycemic constituents of Panax ginseng
13. Ginseng therapy in noninsulin-dependent diabetic patients
14. American ginseng reduces postprandial glycemia in nondiabetic and diabetic individuals
15. Similar postprandial glycemic reductions with escalation of dose and administration time of American ginseng in type 2 diabetes
16. Ginseng pharmacology: Multiple constituents and multiple actions
17. Perspectives on the quality control assurance of ginseng products in North America
18. The glycemic index: Methodology and clinical implications
19. Dosage concentrations in herbal medicine
20. Hemorrheological and circulatory effects of Gincosan
21. Ginseng supplementation does not enhance healthy young adults' peak aerobic exercise performance
22. No ergogenic effect of ginseng ingestion
23. No ergogenic effects of ginseng (Panax ginseng CA Meyer) during graded maximal aerobic exercise
24. Gut and brain effects of American ginseng root on brainstem neuronal activities in rats
25. Effects of tissue cultured ginseng on gastric secretion and pepsin activity
26. Effects of hypoglycemic components in ginseng radix on blood insulin level in alloxan diabetic mice and on insulin release from perfused rat pancreas
27. Interactions of ginseng extract, ginseng separated fractions, and some triterpenoid saponins with glucose transporters in sheep erythrocytes
28. Dietary fibres, fibre analogues, and glucose tolerance: Importance of viscosity
29. Combined use of guar and acarbose in reduction of postprandial glycaemia
30. Assessing the antihyperglycemic effect of acarbose. Solid or liquid test meal?
31. Panax ginseng pharmacology: A nitric oxide link?
32. Effects of ginsenosides on maze performance and brain choline acetyltransferase activity in scopolamine-treated young rats and aged rats
33. Inhibition by ginsenosides Rb1 and Rg1 of methamphetamine-induced hyperactivity, conditioned place preference and postsynaptic dopamine receptor supersensitivity in mice
34. 2+ channels and membrane capacitance in rat adrenal chromaffin cells
35. Ginsenosides that produce differential antinociception in mice
36. The early phase of glucose-stimulated insulin secretion requires nitric oxide
37. Centrally mediated drug-induced hyperglycemia in mice
38. Stimulation of lipid and sugar metabolism in ginsenoside-Rb2 treated rats
39. Studies on the mechanism of the hypoglycemic activity of ginsenoside-Rb2 in streptozotocin-diabetic rats
40. Ginsenosides in roots and leaves of American ginseng
41. Determination of ginsenosides in plant extracts from Panax ginseng and Panax quinquefolius L. by LC/MS/MS
42. Differentiation and authentication of Panax ginseng, Panax quinquefolius, and ginseng products by using HPLC/MS